Hepatocellular Carcinoma
Conditions
Keywords
Transplant
Brief summary
This study aims at testing the utility of PET Scan as a screening tool for liver transplantation in patients with Hepatocellular Carcinoma. Patients being worked up for liver transplant for hepatocellular carcinoma will undergo a PET Scan and will be followed until 2 years after transplantation. At that time survival data will be analysed according to PET Scan results to determine if it can be used to predict outcome.
Interventions
OTHERPET Scan
All patients will have a PET scan as part of their pre-transplant assessment
Sponsors
Pfizer
McGill University Health Centre/Research Institute of the McGill University Health Centre
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Male or female patient over 18 years of age * Diagnosis of HCC confirmed by histology if available or by two imaging modalities * Able to give written informed consent prior to any study specific screening procedures with the understanding that the patient has the right to withdraw from the study at any time, without prejudice.
Exclusion criteria
* Unable to give consent to the study * Unable to undergo a PET Scan
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall Survival | up to death | The primary objective of the study is to compare, according to PET scan results, the post-transplantation overall survival of patients meeting Milan criteria to those not meeting Milan criteria |
Countries
Canada
Outcome results
None listed